Project Details
Description
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) for the Prevention of Adenovirus (AdV) Disease
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/14 → 4/30/18 |
Funding
- CHIMERIX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.